Deutschland – Kaiserreich

Aloxiprin

Clinical data
AHFS/Drugs.com	International Drug Names
ATC code	B01AC15 (WHO) N02BA02 (WHO)
Identifiers
IUPAC name aluminium 2-acetyloxybenzoate hydroxide
CAS Number	9014-67-9
PubChem CID	3032790
ChemSpider	2297682 Y
UNII	6QT214X4XU
KEGG	D07421 Y
CompTox Dashboard (EPA)	DTXSID80889395
ECHA InfoCard	100.041.481
Chemical and physical data
Formula	C18H15AlO9
Molar mass	402.291 g·mol−1
3D model (JSmol)	Interactive image Interactive image
SMILES [Al+3].O=C(Oc1ccccc1C([O-])=O)C.[OH-].[O-]C(=O)c1ccccc1OC(=O)C CC(=O)Oc0ccccc0C(=O)O[Al](O)OC(=O)c1ccccc1OC(=O)C
InChI InChI=1S/2C9H8O4.Al.H2O/c2*1-6(10)13-8-5-3-2-4-7(8)9(11)12;;/h2*2-5H,1H3,(H,11,12);;1H2/q;;+3;/p-3 Y Key:MANKSFVECICGLK-UHFFFAOYSA-K Y
(verify)

Aloxiprin (or aluminium acetylsalicylate) is a medical drug used for the treatment of pain and inflammation associated with muscular skeletal and joint disorders. It is used for its properties as an anti-inflammatory, antipyretic and analgesic drug.^[1] It is a chemical compound of aluminium hydroxide and aspirin.^[2][3]

• Palaprin Forte^[4]
• Askit Powders - A powder combination of aspirin, aloxiprin and caffeine.^[5]

• People with allergies to salicylates.
• People with gastrointestinal ulcers.
• People with liver or kidney damage.
• Pregnant women in the 3rd trimester.
• Women who are breastfeeding.
• Use with other salicylates.
• Use with NSAIDs.

• CTD's Aloxiprin page^{[permanent dead link]} from the Comparative Toxicogenomics Database